Document Detail


Combination antiretroviral use and preterm birth.
MedLine Citation:
PMID:  23204173     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Use of antiretroviral drugs (ARVs) during pregnancy has been associated with higher risk of preterm birth.
METHODS: The Pediatric HIV/AIDS Cohort Study network's Surveillance Monitoring for ART Toxicities study is a US-based cohort of human immunodeficiency virus (HIV)-exposed uninfected children. We evaluated maternal ARV use during pregnancy and the risk of any type of preterm birth (ie, birth before 37 completed weeks of gestation), the risk of spontaneous preterm birth (ie, preterm birth that occurred after preterm labor or membrane rupture, without other complications), and the risk of small for gestational age (SGA; ie, a birth weight of <10th percentile for gestational age). Multivariable logistic regression models were used to evaluate the association of ARVs and timing of exposure, while adjusting for maternal characteristics.
RESULTS: Among 1869 singleton births, 18.6% were preterm, 10.2% were spontaneous preterm, and 7.3% were SGA. A total of 89% used 3-drug combination ARV regimens during pregnancy. In adjusted models, the odds of preterm birth and spontaneous preterm birth were significantly greater among mothers who used protease inhibitors during the first trimester (adjusted odds ratios, 1.55 and 1.59, respectively) but not among mothers who used nonnucleoside reverse-transcriptase inhibitor or triple-nucleoside regimens during the first trimester. Combination ARV exposure starting later in pregnancy was not associated with increased risk. No associations were observed between SGA and exposure to combination ARV regimens.
CONCLUSIONS: Protease inhibitor use early in pregnancy may be associated with increased risk for prematurity.
Authors:
D Heather Watts; Paige L Williams; Deborah Kacanek; Raymond Griner; Kenneth Rich; Rohan Hazra; Lynne M Mofenson; Hermann A Mendez;
Related Documents :
6178293 - The effect of pregnancy on the natural course of diabetic retinopathy.
22689723 - The use of fetal fibronectin testing in the management of a triplet pregnancy with a sh...
135003 - Screening for fetal chromosome aberrations in early pregnancy.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2012-11-29
Journal Detail:
Title:  The Journal of infectious diseases     Volume:  207     ISSN:  1537-6613     ISO Abbreviation:  J. Infect. Dis.     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-01-22     Completed Date:  2013-04-15     Revised Date:  2014-02-18    
Medline Journal Info:
Nlm Unique ID:  0413675     Medline TA:  J Infect Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  612-21     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Anti-HIV Agents / adverse effects*,  therapeutic use
Cohort Studies
Drug Therapy, Combination
Female
Gestational Age
HIV Infections / drug therapy*
HIV Protease Inhibitors / adverse effects*,  therapeutic use
Humans
Infant, Low Birth Weight
Infant, Newborn
Infant, Premature
Pregnancy
Pregnancy Complications, Infectious / drug therapy*
Premature Birth / epidemiology*
Reverse Transcriptase Inhibitors / adverse effects*,  therapeutic use
Risk Factors
Young Adult
Grant Support
ID/Acronym/Agency:
U01 HD052102-04/HD/NICHD NIH HHS; U01 HD052104-01/HD/NICHD NIH HHS
Chemical
Reg. No./Substance:
0/Anti-HIV Agents; 0/HIV Protease Inhibitors; 0/Reverse Transcriptase Inhibitors
Investigator
Investigator/Affiliation:
William Shearer / ; Mary Paul / ; Norma Cooper / ; Lynette Harris / ; Murli Purswani / ; Emma Stuard / ; Anna Cintron / ; Ana Puga / ; Dia Cooley / ; Doyle Patton / ; Deyana Leon / ; Richard Rutstein / ; Carol Vincent / ; Nancy Silverman / ; Ram Yogev / ; Margaret Ann Sanders / ; Kathleen Malee / ; Scott Hunter / ; Andrew Wiznia / ; Marlene Burey / ; Molly Nozyce / ; William Borkowsky / ; Sandra Deygoo / ; Helen Rozelman / ; Katherine Knapp / ; Kim Allison / ; Megan Wilkins / ; Midnela Acevedo-Flores / ; Lourdes Angeli-Nieves / ; Vivian Olivera / ; Hermann Mendez / ; Ava Dennie / ; Susan Bewley / ; Sharon Nachman / ; Margaret Oliver / ; Helen Rozelman / ; Russell Van Dyke / ; Karen Craig / ; Patricia Sirois / ; Marilyn Crain / ; Newana Beatty / ; Dan Marullo / ; Stephen Spector / ; Jean Manning / ; Sharon Nichols / ; Elizabeth McFarland / ; Emily Barr / ; Robin McEvoy / ; Mobeen Rathore / ; Kristi Stowers / ; Ann Usitalo / ; Kenneth Rich / ; Delmyra Turpin / ; Renee Smith / ; Douglas Watson / ; LaToya Stubbs / ; Rose Belanger / ; Arry Dieudonne / ; Linda Bettica / ; Susan Adubato / ; Gwendolyn Scott / ; Claudia Florez / ; Elizabeth Willen / ; Toinette Frederick / ; Mariam Davtyan / ; Maribel Mejia / ; Zoe Rodriguez / ; Ibet Heyer / ; Nydia Scalley Trifilio /
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Identical human papillomavirus (HPV) genomic variants persist in recurrent respiratory papillomatosi...
Next Document:  Impact of neuraminidase inhibitor treatment on outcomes of public health importance during the 2009-...